A kinetic method using a multiinjection proto col, positron emission tomography (PET), and [llC]tlu mazenil as a specific ligand was used to study in vivo the tlumazenil-benzodiazepine receptor interactions in the human brain, The model structure is composed of three compartments (plasma, free, and bound ligand) and five parameters (including the benzodiazepine receptor con centration). The arterial plasma concentration, after cor rection for metabolites, was used as the input function. The experimental protocol, which consisted of three in jections of labeled and/or unlabeled ligand, allowed the evaluation of the five model parameters in various brain regions from a single experiment. In partiCUlar, the con centration of receptor sites available for binding (B'ma X > and the equilibrium dissociation constant (KD V R' V R be ing the volume of reaction) were estimated in five brain regions, including the pons, in which these parameters are identified for the first time (B'max = 4.7 ± 1.7 pmollml and KD V R = 4.4 ± 1. 3 pmol/ml). Due to the large range of measured receptor concentrations, a linear correlation Quantification of the benzodiazepine receptor concentration has been studied by many groups, using positron emission tomography (PET) and [ ll C]flumazenil ([IIC]FMZ), an antagonist with a high affinity and selectivity for central benzodiaze pine receptors (Maziere et al., 1983; Samson et al. , 
between B'max and KD V R was pointed out (r = 0.88, p < 0.0005) and was interpreted as a linear relationship be tween B'max and V R' the parameter KD being assumed constant. This result and its concordance with the pub lished data are discussed. Simulation of the usual two experiment Scatchard analysis, using the pons as a refer ence region, showed that the bias on the receptor con centration estimates introduced by this method is significant (from 20 to 40%) but can be corrected using an estimate of the receptor concentration in the pons. Fur thermore, we propose a new experimental protocol, based on a Scatchard analysis of the PET data obtained with a partial-saturation experiment. This single-injection protocol is entirely noninvasive, and thus the estimation of the benzodiazepine receptor concentration and of the tlumazenil affinity is now possible in human patients us ing a single I-h experiment without blood sampling. Key Words: Benzodiazepine receptors-Compartmental model-p lC]Flumazenil-Positron emission tomogra phy-Scatchard analysis.
1985)
. A quantitative analysis of the in vivo kinetics of flumazenil in the brain is useful for understanding the pharmacological properties of benzodiazepine receptor ligands and for estimating changes in the binding sites for benzodiazepines in pathological conditions. All of the methods that allow estimation of the receptor concentration and the receptor ligand affinity, are based on a mathematical model that includes two steps; first, the transport of the ligand from the plasma to a free ligand compartment (a necessary step since the labeled ligand is injected intravenously) and, second, the classical ligand receptor interaction, similar to that used in in vitro studies. Therefore, the model includes five param-eters (four kinetic parameters and B ' max, the con centration of the receptor sites available for bind ing) .
To reduce the number of parameters to be iden tified, current methods are based on some assump tions , concerning the equilibrium state during the PET study and/or concerning the methods used to estimate the free ligand concentration . The most widely used approach to estimate the benzodiaze pine receptor concentration is the equilibrium ap proach based on a Scatchard analysis , where the free ligand concentration is estimated from data ob tained during a full-saturation experiment (Pappata et aI ., 1988; Iyo et aI ., 1991) , or from a receptor poor region of reference , usually the pons or the white matter in benzodiazepine receptor studies (Savic et aI., 1988; Persson et aI., 1989; Blomqvist et aI., 1990; Price et aI., 1991; Abadie et aI ., 1992) . Recently , Lassen (1993) proposed a new equilib rium method based on the steady-state principle . The experimental protocol includes two experi ments consisting of a constant-infusion injection of ligand , with a high and a low specific activity , re spectively (Lammertsma et aI ., 1993; Prevett et aI ., 1993) . A kinetic approach has been used by Blomqvist et aI. (1990) and Price et aI . (1991) . They propose also to conduct two experiments with dif ferent specific activities, the free ligand concentra tion being estimated from a receptor-poor region of reference (only three parameters are identified) . In a similar approach, Price et aI . (1993) suppressed this last hypothesis , but the number of parameters (five) led to such large standard deviations that, to reduce them, the authors proposed fixing the value of one or two parameters.
In previous papers, we have proposed a kinetic approach, based on a multiinjection protocol and a global fitting procedure. This approach allows the identification of all model parameters from a unique time-concentration curve obtained from a single dynamic PET experiment (Delforge et aI ., 1991 (Delforge et aI ., , 1993a . This approach has two main advantages: First, it relies on no particular hypothesis which can be difficult to justify entirely (such as the equilib rium hypothesis or hypotheses needed for the use of a reference region); second, since all model param eters are identified, it allows various simulations (for example, to test and to evaluate simplified quantitative methods) . This multiinjection approach has been used to study the flumazenil kinetics in baboon brain and to simulate the equilibrium ap proach using an estimate of the free ligand concen tration obtained from a full-saturation experiment (Delforge et aI ., 1993a) . It was concluded that the equilibrium hypothesis is valid for the FMZ kinet-ics, mainly because of the rapid and continuous ex change between the free and the bound ligand com partments . However , this study has also pointed out the importance of obtaining a good estimation of the free ligand concentration , since most of the problems met with this equilibrium approach, such as a bias in the estimates of B' max (an underestima tion of about 12%) and the dependence of the result on the time used for the Scatchard analysis , are probably the consequence of the bias introduced in the estimate of the free ligand concentration (Del forge et aI ., 1993a) .
In the present paper, all the parameter values of the flumazenil-benzodiazepine receptor interaction model are estimated using a three-injection protocol in various regions of the human brain . In particular , an estimate of the receptor concentration in the pons is obtained for the first time. These results reveal a linear correlation between the receptor concentration and the apparent ligand affinity. The validity of this correlation is discussed and com pared with the other published data and a possible interpretation in relation with the concept of reac tion volume is given. The estimation of all model parameters , and in particular , the knowledge of the FMZ kinetics in the pons , has allowed simulation of the equilibrium approach using the pons as a refer ence region . A new protocol, based on this ap proach but permitting estimation of the receptor concentration with only a single injection , is de duced .
THEORY AND METHODS

Synthesis of [ ll C]FMZ
Flumazenil (RO 15 1788) was labeled with carbon-II using the methylation process described by Maziere et al. (1984) . Specific activity of [I l C]FMZ ranged from 400 to 1,200 mCi/j.Lmol.
Experimental protocol
Five healthy male volunteers aged 24 to 30 years (mean age, 26.4 ± 2.5 years), who gave informed consent, were studied. None had a history of psychiatric or neurologic illness and none had taken benzodiazepines.
The protocol consisted of three injections of radiola beled flu maze nil and/or cold flumazenil (see Table 1 ). At the beginning of the experiment, about 15 mCi of [I l C]FMZ was injected intravenously over a time period of about 1 min. The corresponding doses of radioactive tracer, denoted 1(;, ranged from 2. 7 to 11.2 j.Lg. At 29 or 39 min (see Table 1 ), an intravenous injection of unlabeled ligand (0.01 mg/kg) was performed (displacement injec tion). The doses (denoted 11) varied from 0.70 to 0.90 mg, depending on the body weights. At 59 or 69 min, a third injection, consisting of a mixture of labeled (about 8.5 mCi at the injection time) and unlabeled flumazenil in the same syringe (coinjection), was performed. The injected
[IIC]FMZ amounts (In ranged from 6.4 to 38.4 j.Lg; those of FMZ (J2) , from 1.2 to 7.5 mg. The total experiment lasted 103 to 122 min. Details of the doses administered and timing are given in Table 1 . This study was approved by the Ethics Committee of our institution.
PET measurements and datum analysis
PET studies were performed on an ECAT 953B posi tron tomograph, which is a brain imaging system capable of acquiring 31 continuous slices simultaneously (Ben driem et al., 1992) . The axial resolution is 5 mm (full width at half-maximum) and the spatial transverse reso lution on the reconstructed images, with the Hanning fil ter, is 8.4 mm. Transmission scans were acquired with three rotating 68Ge_68Ga sources and used to correct emission scans for the attenuation of 511-ke V photon rays through the tissues and the head support.
Before the study, a 20-gauge Teflon catheter was placed in a radial artery under local anesthesia (1 % xy locaine). The subject's head was then positioned in a head-holder so that the crossed laser beam was aligned with the AC-PC (anterior commissure-posterior commis sure) plane and the PET slices acquired were parallel to the AC-PC line. To define the AC-PC plane, a magnetic resonance imaging (MRl) study was performed with each subject on the same day and just before the PET scan ning. The AC-PC plane was determined on a T I -weighted 7-mm-thick midsagittal MR image. The direction of the AC-PC plane was then reported on the subject's head by means of skin marks.
About 50 sequential PET scans of increasing duration after each injection of labeled FMZ (from 30 s to 5 min) were reconstructed. For datum analysis, five brain struc tures were chosen: the cerebellum, the pons, and the oc cipital, temporal, and frontal cortices. Regions of interest (ROl) were placed over the selected brain structures on selected PET brain levels. These ROls were defined on the early frames (4 min), which represent essentially CBF-related images. Their positions were determined us ing the individual MRI cuts and the corresponding Talair ach atlas levels as guides. The ROI sizes ranged from 120 mm2 (pons) to 300 mm2 (occipital cortex). Concentrations of radioactivity in the different ROI were calculated for each sequential scan and plotted versus time. Radioactiv ity was measured in the selected cerebral structures after J Cereb Blood Flow Metab, Vol. 15, No.2, 1995 correction for IIC decay and is expressed as picomoles per millimeter after normalization using the specific ra dioactivity measured at the time of injection.
Plasma concentration measurements and model input function
The presence of an input function in the model neces sitated the performance of blood sampling. About 50 ar terial blood samples (of about 0.5 ml each) were collected from an arterial catheter previously placed in the radial artery. The time interval between each sample was vari able: Samples were taken every 15 s during the 3 min following the two injections of labeled FMZ, whereas the sampling interval increased to 10 min when the change in the blood radioactivity concentration was slower. After rapid centrifugation of a part of the whole blood, the plasma IIC radioactivity was measured using a gamma counting system (CG 4000; Kronton, France). The time activity curves were corrected for physical decay of IIC activity and the whole-blood and plasma radioactivity concentrations were transformed into ligand time concentration curves using the specific radioactivity of [IICJFMZ.
It has been shown previously that flumazenil metabo lites cannot cross the blood-brain barrier (Inoue et al., 1985) . Thus, the nonmetabolized [llCJFMZ plasma con centration is used as the input function of the model. The percentage of nonmetabolized [llClFMZ in plasma de creased for 20 min after injection and remained essen tially constant after this time. This percentage, denoted P nm(t), could be described by a monoexponential curve, Pnm(t) = A + (100 -A)e-Bt, where t is the time ex pressed as minutes. For each experiment, P nm(t) was measured at five time points by thin-layer chomatography (Loc'h et al., 1990) . The mean coefficients obtained (A = 44 ± 13, B = 0.12 ± 0.05) were very close to the results obtained by Debruyne et al. (1991) (A = 40 ± 6) but appear to be higher than those of Price et al. (1993) 
The ligand-receptor model
The compartmental model used in this study, and shown in Fig. 1 , is a nonequilibrium nonlinear model (Sy rota et al., 1984 (Sy rota et al., , 1985 Delforge et al., 1991 Delforge et al., , 1993a . The flux of nonmetabolized free ligand from the plasma com- has an effect on the local concentration of free receptor sites and, consequently, on the binding probability of free labeled ligand. N.S., nonspecific.
partment to the free ligand compartment is given by k1C:(t) (as pmol/min/mltissuJ, where C:(t) is the plasma concentration of non metabolized [ ll C]FMZ (as pmoll ml p l a,ma) deduced from the [I l C]FMZ plasma concentra tion using P nm(t). The quantity of free labeled ligand present in 1 ml of the tissue volume delineated by PET is denoted by M;(t). However, to take into account the tis sue inhomogeneity, it is necessary to introduce the vol ume of reaction denoted V R (as mltissuelmltissue). By def inition, the value of V R is such that M;(t)IV R is equal to the local free ligand concentration in the neighborhood of the receptor sites (see the next section). The free ligand can bind directly to a free receptor site or escape back to the blood circulation with a rate constant k2• The specific binding probability depends on the bimolecular associa tion rate constant (kon), on the local free ligand concen tration [M;(t)IV R ], and on the quantity of free receptor sites in 1 ml of tissue, which is equal to [B'max -M�(t)], M�(t) being the quantity of labeled ligand bound to recep tors in 1 ml of tissue. The rate constant for the dissocia tion of the specifically bound ligand is denoted ko ff'
The protocol described in a previous section includes injections of unlabeled ligand. Thus, the kinetics of the unlabeled ligand affects the local concentration of free receptor sites and must therefore be taken into account.
The amount of the free unlabeled ligand is denoted Mr<t); that of specifically bound unlabeled ligand, Mb(t) (both expressed as pmol/mltissue). The unlabeled ligand kinetics are assumed to be identical to that of the labeled ligand and thus the two parts of the model, associated with the labeled and unlabeled ligand, respectively, have the same structure and the same parameters. The plasma concen tration of the unlabeled ligand [denoted CaCm was calcu lated by simulation using the curve C!(t) corresponding to the labeled ligand. It is assumed that nonmetabolized plasma curves have similar shapes and are proportional to the mass injected for each separate injection. Comparison of the plasma curves after a tracer injection and after a coinjection and published results showing no significant difference between high-and low-specific activity kinet-ics of unmetabolized FMZ (Price et aI., 1993) justify this assumption.
Parameter identification and simulations of labeled and unlabeled ligand kinetics were performed using the fol lowing equation system (which corresponds to the model diagram in Fig. 1) :
where B'max, k1, k2, konlVR, and kof f are the identified parameters. Units are given in Tables 2 and 3. The two parameters kon and VR cannot be separately estimated since they always appear together in Eqs. 1-4. In PET studies, experimental data [denoted M{(t;l] acquired between two times (denoted ti-1 and t;l is given by the following integral relation:
where C�(t) is the whole-blood time-concentration curve and Fy represents the fractional volume corresponding to 
the fraction of blood present in the tissue volume. In this study, Fv is assumed to be 0.04 (Perlmutter et al., 1986; Farde et al., 1989; Koeppe et al., 1991) . The model parameters are identified by means of min imization of the usual weighted least-squares cost func tion and the estimation of the standard errors is based on the use of a sensitivity analysis and the covariance matrix (Beck and Arnold, 1977; Carson, 1986; Delforge et al., 1989 Delforge et al., , 1991 .
The volume of reaction V R
The volume of reaction has been introduced to take into account the ligand concentration inhomogeneity, re sulting from tissue inhomogeneity and ligand properties such as lipophilicity. This tissue inhomogeneity is well known, but there is an inconsistency between these ob vious data and the assumed homogeneity of the concen tration of ligand molecules in the free ligand compart ment. For example, it is not obvious that the local concentration of the free ligand in the neighborhood of the receptor sites [denoted ct(t), which is the concentra tion to take into account in the ligand-receptor interac tions] is equal to the mean concentration in the unit vol-ume measured by PET [denoted Mt(t) in Eqs. [1] [2] [3] [4] . How ever, if an equilibrium state is rapidly reached inside the free ligand compartment, the ratio Mt(t)/ct(t) is a con stant that defines the volume of reaction. Thus, to de scribe the local association and dissociation reactions, it is necessary to consider the true local concentrations
within the fictive volume of reaction VR, rather than the quantities Mt(t) in I ml of tissue. The quantities "per milliliter of tissue," which are the units used in the equation system 0-4), are thus obtained after multiplication by VR• This approach does not modify the equaiion of the linear reactions (such as the dissociation) but introduces a term lIV R in the specific binding since it is a bimolecular reaction. In conclusion, VR is a parame ter that allows the introduction of the global effect of the tissular inhomogeneity in the ligand-receptor interac tions. It is justified in the same way as the usual concept of the volume of distribution, which describes the global effects of the tissular inhomogeneity in the transfers be tween the plasma and the free ligand compartment. In both cases, the volume is a fictive volume in a unit vol ume of tissue (as mltis.",/mltissue), which, however, can be greater than one. Figure 2 shows two examples of time-concen tration curves obtained with this multiinjection pro tocol . These two curves correspond to the occipital cortex and pons, respectively (see exact doses and timing in Table 1 , experiment 3). After the first in jection of [I l C]FMZ with a high specific activ!ty, the radio ligand concentration increases over time and reaches its maximum (all the more rapidly as the receptor concentration is low: about 5 min after the injection for the pons and about 10 min for the occipital cortex) .
RESULTS
Brain time-concentration curves
The injection of a large amount (0.01 mg/kg) of unlabeled ligand at 39 min results in a rapid de crease in the e l C]FMZ concentration, showing a fast dissociation of the labeled bound ligand from the receptor sites . The percentage of displaced mol ecules is about 70% for the occipital cortex and about 50% for the pons . The last result is important since in contrast to the usual hypothesis, it shows that i� the pons about 50% of the labeled ligand is bound to receptor sites after a tracer injection . About 10 min after the displacement, the decrease in the PET concentrations is negligible and the curves reach a plateau level .
:g
The coinjection of labeled and unlabeled FMZ at 69 min produces a fast peak in time-concentration curves, which contrasts with the smoother curves . mln) (see exact doses in Table 1 , experiment 3). In t�e occIpital cortex the estimated model parameters were S max = 63.3 pmol/�I, konlVR = 0.115 ml/(pmol min), koff = 1.08 min -\ k 1 = 0.37 min -1, and k2 = 0.56 min -1. In the pons, the esti mated model parameters were S' max = 4.2 pmol/ml, kon/VR = 0.265 ml/(pmol min), koff = 1.09 min -\ k 1 = 0.23 min -1, and k2 = 0.39 min-1.
observed when labeled ligand is injected alone . All the curves are always decreasing during the 50 min after this last injection .
In Fig. 2 , the two lines correspond to the fits obtained from the model. No systematic bias was observed between the model simulations and the experimental data, indicating that the structure of the model is well adapted for the study of the flu mazenil brain kinetics .
Parameter identification
Fitting the mathematical model to experimental data provides values for kinetic rate constants and receptor densities . As an example, Table 2 shows the individual estimates of all model parameters corresponding to the temporal cortex in the five vol unteers . An estimate of the standard error was ob tained for each identified parameter using the co variance matrix . This value measures the error es timates that result from the differences between the model-predicted values and the experimental data due to experimental uncertainties and approxima tions in the model structure .
Mean parameter values and standard deviations have been calculated for the five volunteers in the five brain regions (Table 3 ). The standard devia tions permit the estimation of the influence of var ious uncertainties unrelated to the fit results: indi vidual variability, various instrumental errors, and uncertainties in various measurements such as the specific activity, the blood sample concentrations, or the metabolite corrections . The largest receptor density has been found in the occipital cortex (88 ± 28 pmollml tissue), but it is not much smaller in the temporal and frontal cortices (65 ± 18 and 63 ± 20 pmol/ml tissue, respectively). However, we have measured a smaller B'max value in the cerebellum (21 ± 10 pmollml tissue) and found a very low re ceptor concentration in the pons (4.7 ± 1.7 pmol/ml tissue). This is the first in vivo estimate of the re ceptor concentration in the pons . The estimates of the parameter Kd VR, calculated from the ratio of the two identified parameters kon/V R and k O ff' are simi lar in the first three regions (from 12.5 to 10.9 pmol/ ml) but are somewhat smaller in the cerebellum (7.0 ± 1.9 pmol/ml) and very small in the pons (4.4 ± 1.3 pmol/ml) .
These results also show a correlation between the 
.9: separately the correlation between these two pa rameters and B'max' Figure 3B shows that the ko ff parameter appears to be independent of B' max (koff One of the interesting features of the kinetic ap proaches is the ability to estimate the time concentration curve in all compartments . As an ex ample , Fig . 4 shows the estimates of the labeled free, bound, and total ligand concentrations calcu lated using the model parameters obtained from the occipital cortex data (Fig. 4A ) and from the pons data ( Fig. 4B ) during experiment 3 (see the detailed protocol in Table 1 and the parameter values in the legend to Fig. 2) . The concentrations measured with PET (shown in Fig. 2 by the lines and in Fig. 4 by the solid lines) are the sum of the e I C]FMZ con centrations in the free and bound compartments and of a fraction Fv of the [ II C]FMZ blood concentra tion, assumed to be equal to 4% in this study. These calculations point out differences between the ROI. After injection of a tracer dose with a high specific activity, most of the radioligand is specifi cally bound to receptors in the receptor-rich brain regions (see the example of the occipital cortex in Fig. 4A) , whereas in the pons, a receptor-poor re gion, about 50% of the ligand is free.
The injection of unlabeled ligand at 39 min causes a rapid decrease in the labeled bound ligand con centration, which remains higher than the free ligand concentration in the occipital cortex but be comes negligible in the pons. In both regions, a tem porary increase in the free ligand concentration is observed.
After the coinjection of labeled and unlabeled ligand at 69 min (which is equivalent to an injection with a low specific activity), the free ligand concen tration is higher than the bound ligand concentra tion in both regions. However, the ratio bound/free remains variable 50 min after this last injection (the free ligand concentration is decreasing, whereas the bound ligand concentration appears to be almost constant).
Computer simulation of the two-experiment
Scatchard approach
Major limitations of the kinetic approaches are the need to measure the model input function (and thus to perform a metabolite analysis) and to use complex protocols to produce experimental data that allow identification of five parameters with ac ceptable standard deviations. Such protocols can appear impractical in human studies and routine ex aminations and various simplified approaches to es timating the receptor concentration have been pro posed. For example, many authors would like to use the usual in vitro methods in PET studies, such as the Scatchard analysis based on the equilibrium The main interest is that the number of parameters is advantageously reduced (only two parameters :
B'max and Kd V R) and that blood sampling (and thus a metabolite study) is not necessary. However, it requires, first, separately estimating the free and the bound ligand concentrations (the PET data giv ing only the sum of these two concentrations) and, second, obtaining a large range of bound ligand con centrations, which has led some authors to perform several experiments with various specific activities in the same subject.
To simplify this protocol drastically, some au thors have proposed, first, estimating the free ligand concentration in a reference region (assumed to be devoid of receptor sites and to have the same distribution volume as the region of interest) and thus deducing the bound ligand concentration by subtracting this free ligand concentration to the to tal PET-measured concentration and, second, per forming only two experiments : the first with a high specific activity and the second with a low specific activity (Fig. 5A ). This is the usual two-experiment Scatchard approach (Savic et at., 1988; Blomqvist et at., 1990; Abadie et at., 1992) .
U sing all the model parameters identified in hu mans with the multiinjection approach (see Table   3 ), this Scatchard-equilibrium approach has been simulated to estimate its validity and to test each hypothesis . Figure 5A shows the simulation of the PET time-concentration curves in the temporal cor tex and in the pons, resulting from a tracer injection of e I C]FMZ (left) and from a coinjection of a tracer dose of e I C]FMZ and 0.025 mg/kg FMZ (right). .... responding to the temporal cortex (Cts; see Table 3 ). The doses of [11C]FMZ (denoted d*) are the same in both exper iments; the dose of FMZ (denoted by d) used to obtain a low specific activity in the second experiment was 0.025 mg/kg body weight. 8 and F, the bound and free ligand concentra tions, respectively. B shows the Scatchard analysis of these simulated data. The different symbols correspond to differ ent estimates of F and 8 at various measurement times. The inverse of the straight-line slope gives KdVR and the intercept of a straight line with the 8 axis gives the receptor concen tration, 8' max '
Proposition of a single-injection PET
Scatchard analysis
In spite of this bias, the Scatchard method has some advantages such as the absence of arterial blood sampling. However, even with the simplest protocol, it is still necessary to perform two exper iments for each patient (see the previous section). It would be interesting to avoid this double experi ment and to find a method allowing estimation of the receptor concentration from a single experi ment. In Fig. 5B , the different symbols correspond to the different measurement times used for the Scatchard analysis, and it appears that B, the con centration of bound ligand, significantly decreases over the duration of the experiment. Therefore, we propose performing a partial-saturation experiment J Cereb Blood Flow Metab, Vol. 15, No. 2, 1995 and using this natural decrease in the bound ligand concentration to estimate B'max and Kd V R from a single-injection experiment.
Let us consider the simulated PET curves ob tained after a coinjection of a tracer dose of e I C]FMZ and of 0.025 mg/kg of FMZ, as shown on the right in Fig. 5A . The percentage of occupied receptor sites ranged from about 80% at 10 min to 35% at 2 h (55% at 1 h). The choice of the unlabeled dose is important, since it has to be sufficiently large to occupy a significant percentage of receptor sites, but not too large, since it must allow a signif icant decrease in this percentage during the limited duration of the experiment. Figure 6 shows the Scatchard plot obtained from these simulated curves describing such a partial-saturation experi ment and using various measurement times, ranging from 5 min to 2 h. The free ligand concentration is estimated using the pons. The bound ligand concen tration in the ROI (temporal cortex), obtained by subtracting the free ligand concentration from the total PET-measured concentration, decreases from 57 pmollml at 5 min to 27 pmollml at 2 h. Except for the early data, the points appear on a (dotted) straight line, which allows estimation of B' max (76 pmol/ml) and Kd V R (17 pmollml). By comparing this dotted straight line with the theoretical Scatchard plot, represented by the solid straight line, it ap pears that B' max and Kd VR are again overestimated, by about 16 and 50%, respectively. However, com- Bound Ligand Concentration (pmol/ml) FIG. 6. Simulated Scatchard analysis using a partial saturation experiment. This Scatchard plot has been ob tained using only the simulated curves corresponding to a unique partial-saturation experiment (right-side curves in Fig. 5A ) and using the pons as the reference region. All the points represented by different symbols correspond to vari ous Scatchard analysis times, including a large range of time (from 5 min to 2 h). Except for the first times, the points appear on a straight line, which allows, using the usual method, estimation of 8' max (76 pmol/ml) and KdVR (17 pmol/ ml). By comparing this straight line with the theoretical Scat chard plot represented by the solid straight line, it appears that 8'max and KdVR estimates are overestimated. (8), and the absence of receptor sites in the pons (C). A was obtained using the free and bound ligand concentrations calculated by simulation and thus as sumed to be known without error. It proves that the approx imation concerning the validity of the Scatchard equation has a negligible effect. In S, the free concentration F is the simulated free ligand concentration in the pons (to suppress the effects of a small concentration of receptor sites in the pons). It shows the overestimation of both the bound/free ratio and the bound ligand concentration, resulting from the difference between the volume of distribution (ratio k,/k2) in the temporal cortex (0.57 mllml) and in the pons (0.50 mllml). The effect of a low concentration of receptor sites in the pons (4.7 pmol/ml) is shown in C. To simulate only this effect, the Scatchard analysis was simulated by assuming identical vol- '.
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Bound Ligand Concentration (pmollml) umes of distribution. (With this hypothesis and since the equilibrium state is rapidly reached, the free ligand concentrations in the pons and in the ROI are similar.) Simulations show that the concentration of ligand bound to pons receptor sites ranged from 4.5 pmol/ml at 3 min to 2.8 pmollml at 2 h and that the overestimation of the free ligand concentration ranged from about 4% at 3 min to 30% at 2 h. It results in an underestimation of both the bound/free ratio and the bound ligand concentration.
parison of the two extrapolated straight lines in
Figs. 5B and 6 shows that this bias is less important with this new method than it is with the classical two-experiment method. Figure 6 shows that the straight line is clearly defined even when only the data corresponding to the first hour of the experiment are considered. Consequently, a I-h experiment appears sufficient to estimate B'max and Kd VR, although the longer the duration of the experiment, the smaller are the un certainties in these two parameter estimates.
Study of the bias
The existence of a bias is common to the usual two-experiment protocol and to the partial saturation single-injection protocol. Three hypoth eses introduced in these approaches can explain this bias: the approximation concerning the validity of the Scatchard equation, the hypothesis about the identical distribution volumes in the various re gions, and the assumption concerning the absence of receptor sites in the reference region.
To check the validity of the first hypothesis (the validity of the Scatchard equation), the partial saturation method has been simulated using the free and the bound ligand concentrations obtained from the simulation and, thus, assumed to be known without error. Figure 7 A shows that the bias ob served on the corresponding Scatchard plot is then very small, which proves that the approximation concerning the validity of the Scatchard equation (the only approximation made here) has a negligible effect. This result agrees with the results published by Delforge et al. (1993a) demonstrating that the equilibrium equation is valid with FMZ, except dur ing a short period of time after the injection.
The second hypothesis concerns the equality of the volumes of distribution in the ROI and in the reference region. In this simulation, this is not ex actly true, since the volume of distribution (ratio k1lk2) is equal to 0.57 mllml in the temporal cortex, whereas it is only 0.50 mllml in the pons (see Table  3 ). This difference leads to an underestimation of the free ligand concentration in the temporal cortex and therefore to an overestimation of both the bound/free ratio and the bound ligand concentra tion. The bias introduced by the approximation con cerning the distribution volume is illustrated in Fig.  7B . This figure was obtained using, as the free con centration F, the simulated free ligand concentra tion in the pons (this method eliminates the bias introduced by the third hypothesis). It appears that the slope of the straight line, giving Kd V R' is not modified and the bias introduced in the B'max esti mate is <10%. From these results, and since the volumes of distribution have the same order of mag nitude regardless of the region of interest [see Table  3 and Millet et a1. (1995) ], the bias resulting from the second hypothesis appears to be acceptable.
The last hypothesis is that the reference region (usually the pons in benzodiazepine studies) has no receptor sites. However, using the multi injection approach, the concentration of receptor sites in pons has been estimated to be �4. 7 ± 1.7 pmol/ml (see Table 3 ), which is small but not negligible. Con sequently, the PET-measured [ ll C]FMZ concentra tion in the pons is not equal to the free ligand con centration since this measurement includes the con centration of labeled ligand bound to receptors. For example, after an injection of only a tracer dose of [ l l C]FMZ, �50% of the PET-measured concentra tion in the pons corresponds to ligand bound to re ceptor sites (see Fig. 4B ). Since the coinjection of [ ll C]FMZ and FMZ, used in the partial-saturation protocol, includes 0.025 mg/kg body weight of FMZ, most of the receptor sites in the pons are occupied by the ligand (from �95% at 3 min to 60% at 2 h). The resulting concentration of ligand bound to the pons receptor sites ranges from 4.5 pmollml at 3 min to 2.8 pmollml at 2 h (3.5 pmol/ml at 1 h), and the overestimation of the free ligand ranges from �4% at 3 min to 40% at 2 h (25% at 1 h). Figure  7C shows the corresponding Scatchard plot; the overestimation of the free ligand concentration causes an underestimation of both the bound/free ratio and the bound ligand concentration. It is in teresting to note that the smaller bias obtained with the new partial-saturation protocol (Fig. 6) , com pared with the bias observed with the classical two experiment method (Fig. 5B) , is the consequence of a higher overestimation of the free ligand concen tration in a high-specific activity experiment (�50% at 2 h) than in a low-specific activity experiment (�40% at 2 h).
In conclusion, this study of the bias introduced by the Scatchard analysis of a partial-saturation ex periment (see Fig. 6 ) shows that it is the conse quence mainly of a low concentration of receptor sites in the pons. However, it is easy to decrease J Cereb Blood Flow Metab, Vol. 15, No. 2, 1995 this bias by estimating the concentration of the la beled ligand bound to receptor sites in the pons and, thus, by making a correction in the estimate of the free ligand concentration. The measurement of the concentration of occupied receptor sites in the pons for each patient is possible using a displacement experiment at the end of the partial-saturation ex periment, although this implies increasing the dura tion of the experiment by at least 30 min. This dif ficulty can be avoided by using a constant correc tion independent of the patient deduced from the mean model parameter values (Table 3) . For exam ple, taking into account the doses used, the simula tion allows estimation of the concentration of occu pied receptor sites in the pons at the end of the experiment (about 2.8 pmollml with the doses used in our example). If the free ligand concentration is now estimated by subtracting this value from the total PET-measured ligand concentration in the pons, a great part of the bias appears corrected, as shown in Fig. 8 (the bias is �6% for B' max and negligible for Kd V R) ' The residual bias is due to the different dis tribution volumes and the variation of the concen tration of occupied receptor sites in the pons (only the concentration at the end of the experiment can be estimated using a displacement injection).
DISCUSSION
Experimental protocols
The major interest in PET studies of ligand receptor interactions is the possibility to estimate in Figure 7 shows that the bias introduced by a Scatchard analysis of the partial-saturation experiment (see Fig. 6 ) is the consequence mainly of a low concentration of receptor sites in the pons. Simulations show that the concentration of occupied recep tor sites in the pons is �2.8 pmol/ml. The Scatchard plot was obtained by subtracting this value from the concentration measured by PET in the pons. A major part of the bias was then corrected, the residual bias being the consequence mainly of the difference between the distribution volumes.
vivo, for each subject, both the receptor concentra tion and the ligand affinity . The best approach is to identify all the model parameters from PET data, since this avoids introducing some simplifying hy potheses, which are difficult to justify without a thorough understanding of the ligand kinetics and which can lead to bias in the results . Moreover, complete knowledge of the model parameters is necessary to make simulations that permit detailed studies 'of the kinetics of the ligand in each compart ment' validation of simplified methods, and optimi zation of experimental protocols . However, the complexity of the model requires the use of com plex protocols that are difficult to manage with pa tients . Thus, a good modeling strategy includes two steps: first, preliminary studies on animals and on human volunteers using complex protocols (to ob tain relevant information about the ligand kinetics) and, second, a simplification of the experimental protocol (based on hypotheses justified by these preliminary results about the ligand kinetics) that allows application for routine patient studies .
In the first step, the difficulty is to estimate the receptor concentration and all kinetic model param eters from only a single experiment (to avoid the practical difficulties of the multiexperiment proto cols, for example, the errors due to repositioning) . Because of the large number of parameters, the only possibility is to use a protocol including mul tiple injections of labeled and/or unlabeled ligand [see Delforge et aL (1990) for a discussion of the necessity to maintain a balance in the respective complexities of the model structure and the exper imental protocol] . The protocol used in this human study (which included three injections) was simpler than the protocol used previously in baboons (Del forge et aI ., 1993a), which included four injections (a second displacement injection was performed) and two syntheses because of the long duration of the experiment (220 min). This simplification of the experimental protocol may increase the stan dard deviations of the estimated parameters . How ever, the comparison between results obtained with the four-injection protocol (Delforge et aI ., 1993a) and the three-injection protocol ( Table 2) shows that the standard deviations increased mainly for the parameters kon/V R and k Off ' whereas the stan dard deviations corresponding to the ratio of these two parameters (Kd V R) and to B'max were only slightly altered.
An alternative approach to estimating all the model parameters is the two-experiment approach (with high and low specific activity injections) pro posed by Price et aL (1993) . However, in spite of the sophisticated methodology (a thermoplastic mask is used in conjunction with x-ray computed tomography to localize the planes of interest), the necessity of two distinct experiments is an incon venience. Moreover, this protocol does not include a displacement experiment, and thus, it is not sur prising that the standard deviations obtained by Price et aL are often larger than those obtained in the present study . To improve the standard devia tions, these authors have to fix some of the param eters [see methods II and III of Price et aL (1993) ].
Because of the long experiment duration, the three required injections (including two injections of labeled ligand), and the blood sampling and me tabolite studies, the protocol used in the present study appears to be unsuitable for routine patient examinations. This emphasizes the importance of the second step of our modeling strategy, which consists of simulating and optimizing simplified pro tocols . This step is possible since all the model pa rameters have been previously estimated. Our sim ulations led to a new protocol based on a Scatchard analysis of a single partial-saturation experiment and using the pons as the reference region. This method introduces a bias, due mainly to the small number of receptor sites in the pons, but we have shown that this bias is smaller than the bias ob tained with the two-experiment approach. More over, it can be dramatically reduced by using a cor rection based on the estimation of the ligand con centration bound to pons receptor sites. This proposed protocol is very simple and allows the es timation of B' max and Kd V R from a single I-h exper iment, without blood sampling and metabolite cor rection .
Model parameter estimates
The quantities of receptor sites available for in vivo binding estimated by this modeling approach have been found to be high in the occipital, tempo ral, and frontal cortices (from 88 to 63 pmollml) but lower in the cerebellum (21 ± 10 pmollml). These values have the same order of magnitude as other published B'max estimates (see Delforge et aI ., 1993a , Table 4 ; Lammertsma et aI., 1993; Price et aL 1993) , although the receptor concentration in the cerebellum is lower than published values (from 20 to 62 pmollml).
To the best of our knowledge, no estimate of the benzodiazepine receptor concentration in the pons, measured in vitro or in vivo, is available. Lam mertsma et aL (1993) found an estimate of the re ceptor concentration in the brain stem (2 ± 2 pinol/ ml) but considered in their discussion that this value is not significant. However, the estimation of the receptor sites in the pons is very important, since the pons is used by many authors as a reference region and, consequently, is assumed to include no receptor sites . Usual methods do not allow the es timation of B'max in ROI, including a low concen tration of receptor sites, since they lead to very large standard deviations of parameters estimates or unacceptable results [e .g., the negative values found by Blomqvist et al . (1990) and Lammertsma et ai . (1993) ]. Thanks to the multiinjection ap proach, the receptor concentration in the pons has been estimated for the first time (4 .7 ± 1.7 pmol/ mI). This nonnegligible concentration of receptor sites is also supported by the decrease in the radio ligand concentration in the pons following an injec tion of a large dose of FMZ (displacement injection; see Fig. 2 ). Previously, the presence of receptor sites in the pons was pointed out by Persson et ai . (1989) , who compared the PET time-concentration curves obtained with and without a protection dose (10 mg dose of FMZ injected 10 min before the la beled FMZ injection).
Our modeling approach also allows the estima tion of the kon/VR and ko ff parameters and, thus, of the combined Kd V R parameter . The estimated val ues ranged from 12 .5 to 7.0 pmoIlml for all regions except the pons, where it was significantly smaller (4 .4 pmollml) . Other authors using PET did not in clude in their models the volume of reactions, and therefore, the Kd V R values obtained in this paper must be compared with the Kd values obtained by these authors who have implicitly sct V R to I. The estimates of Kd V R have the same order of magni tude, regardless of the authors and the approaches used (see Delforge et aI., 1993a , Table 4; Lam mertsma et aI ., 1993; Price et aI ., 1993) .
The estimates of the k l parameter (from 0.27 to 0.41 min -I , depending on the region; mean, 0.35 ± 0.04 min -I ) are close to, although a little bit larger than, the value obtained by Price et al . (1993) (from 0.22 to 0.33 min -I ; mean, 0.30 ± 0.04 min -I ). This k l parameter is also identifiable using the two compartmental model, and the values obtained by Koeppe et al. (1991) (from 0.31 to 0.20 min -I), by Gilman et al. (1991) (from 0.28 to 0.32 min -I), and by Holthoff et ai . (1991) (from 0.29 to 0.37 min -I ) are similar . The estimates of the k2 parameter (0 .59 ± 0.06 min -I ) and of ko ff (0 .79 ± 0.06 min -I ) ob tained in this study have the same order of magni tude, although they are a little bit larger than the estimates obtained by Price et ai . (1993) (k2 = 0.37 ± 0.08 min -1 and koff = 0.48 ± 0.24 min -I).
No systematic bias has been observed in the com parison of the experimental data and of the model simulations, which argues in favor of the structure of the mathematical model. In particular, this con-J Cereh Blood Flow Metab, Vol. /5, No .2, /995 firms that a nonspecific binding compartment does not need to be introduced: Either the nonspecific binding is negligible, as pointed out by Goeders and Kuhar (1985) , or a weak nonspecific binding exists, but with association-dissociation kinetic rate con stants large enough so that it can be included in the free ligand compartment (Mintun et aI., 1984; Perl mutter et aI ., 1986) . In the latter case, a parameter denoted 12 , which is the fraction of drug free of nonspecific binding, can be included in the binding probability of a free ligand . However, this parame ter 12 cannot be estimated from PET data, which allow estimation of only the combined parameter I2 kon/VR ' Some authors proposed estimating I2 from the free fraction of FMZ in plasma, denoted I I , by the relationship 12 = (k2/k l )I I (Mintun et aI ., 1984; Gjedde and Wong, 1990) . Setting the parameter I I equal to 0.50 (Price et aI ., 1993) J2 is estimated from our results (Table 2) as �0.88, which leads to the fraction of nonspecific binding included in the free ligand compartment being estimated as � 12%.
The volume of reaction is not directly identifiable by PET since the local free ligand concentration in the neighborhood of the receptor sites is unknown . However, V R can be estimated by comparing the Kd V R values measured in vivo (Table 3) with the estimates of Kd obtained by in vitro methods . Using the in vitro results obtained by Kopp et ai . (1990) , 6.1 pmol/ml in human neocortex, the volume of re action between FMZ and the benzodiazepine recep tors is estimated as � 2.1 mi/mi . However, one must be cautious when comparing in vivo and in vitro results since the latter have their own technical lim itations related to tissue homogenization and filtra tion .
The method proposed by Delforge et ai . (1993a) to estimate VR from the parameters k l = pVR and k2 = p, is not applicable with the FMZ [as it is with other molecules, e.g., with methylquinucJidinyl benzilate (MQNB) (see Delforge et ai. 1993b )], since a recent theoretical study shows that this method assumes that the concentration of the free ligand in the neighborhood of the capillaries is equal to the concentration in the neighborhood of the re ceptor sites (results not yet published).
Correlation between B'max and Kd V R Figure 3A pointed out a linear correlation be tween the two model parameters B'max and Kd VR.
This result is surprising at first, since the parameter Kd VR (usually denoted Kd) estimated in vivo by PET is usually considered to be a constant indepen dent of the receptor concentration. A possible de pendence between the receptor concentration and the affinity has not been observed in in vitro studies and would be difficult to explain from a theoretical point of view. Therefore , if a correlation between B'm a x and Kd V R is proved from PET data, the sim plest explanation is the existence of a linear corre lation between the volume of reaction V R and the receptor concentration B'm a x , the affinity being as sumed a constant.
To verify this possible correlation, we have stud ied all sets of published data which included esti mates of B'm a x and Kd V R in at least 4 regions of interest. For each set of data, a linear correlation has been tested and the detailed results are given in Table 4 . Using a linear relation, it appears that Kd V R is increasing with B'm a x for all data sets. The relevance of the linear correlation is measured by the correlation coefficient r and by the probability p that this correlation is obtained by random. Except for two data sets, all coefficients ra re >0.70, and for five data sets, they are >0.85. The probabilities p are <6% for 8 data sets (on 12) and are <0.05% for all the studies including more than 14 pairs of values (B'max, Kd V R)' For statistical reasons (only 2 or 3 df) , it is not surprising that p is worse when only fo ur or fi ve ROI are studied. In fac t, the correlation between B'm a x and Kd V R is often difficult to prove because of the large standard deviations usually ob tained , whatever the approach. Consequently, this correlation can be pointed out only if a large num ber of ROI are studied (Abadie et al., 1992; Millet et al ., 1995) or if the range of receptor concentrations is large (this study) . The extension of this range of receptor concentrations is possible only by using the receptor-poor regions and implies that the ap proximations made in the parameter estimation methods are not too biased in these regions. The multiinjection approach appears well adapted to es timate the concentration in these receptor-poor re gions , since no particular hypothesis is introduced, and it avoids the difficulties resulting from the mul tiple-experiment protocol, which have their maxi mum effe ct in these regions.
In Table 4 , the third correlation obtained from Price's results and the second correlation from Lammertsma's results are not convincing. In the first case, the data set was obtained by fitting only three parameters , the parameters k on lV R (usually denoted k o n) and kl/k2 being fixed (method III of Price et al . 1993 ). These constraints can explain why the correlation among the five reported (B'm a x , Kd V R) pairs partially disappears . The second case concerns the results of Lammertsma et aI ., which were obtained using a new equilibrium method (Lassen, 1993) . The Kd VR estimates are open to criticism in the receptor-poor regions (1.5 ± 3.5 pmol/ml in the brain stem and a negative value , -7.5 ± 8.7 pmol/ml, in the white matter) . If these two ROI are not considered, the linear correlation between B' max and Kd VR is not proved (r = 0.34, p = 0.4 1; see Table 4 ), whereas this correlation is significant if the brain stem results are included (r = 0.72, p = 0.03). Taking into account the relation ships between B' max and Kd VR (Eqs. 15 and 16 of Lassen, 1993) , a possible explanation of these very small or negative values is that the k/k2 values used (denoted X. and ranging from 0.69 to 1.00) are over estimated by the method used by . This explanation is suggested by the k/k2 values obtained in this paper with the kinetic ap proaches (from 0.5 to 0.65; see Table 3 ) and by the results of Price et al. (1993) (0.68 ± 0. 17 and 0.55 ± 0.19 in the pons and white matter, respectively). In conclusion, although some correlations described in , 1988) . This explanation is clear only for the Scatchard analysis , but a similar common dependence of B' max and Kd V R on experimental un certainties cannot be excluded with the other meth ods. However, this explanation cannot be valid for the correlation obtained in this paper with the mul tiinjection approach, since this correlation has been pointed out from the values corresponding to vari ous brain regions with a large range of receptor con centrations and of ligand affinities. Consequently, the points of the Scatchard plot (pairs of values: B and BIF) , and the corresponding straight lines asso ciated with different ROI, are in various positions, which are not related to the influence of the exper imental errors.
J Cereb Blood Flow Metab, Vol. 15, No. 2, 1995 The correlation between B' max and Kd V R can also be created by a bias resulting from the hypotheses introduced in the parameter estimation methods. However, all the methods used in the studies re ported in Table 4 were different with various hy potheses. In the multiinjection approach, there are only two hypotheses: first, the structure of the model and , second, the ability to estimate the plasma concentration of the unlabeled ligand [Ca(t)] from the measured concentration of the labeled ligand [C:(t)]. Simulations show that the uncertain ties in Ca(t) have little influence on the parameter estimates (the fitting procedure concerns only the labeled ligand concentration curve) and , therefore , that these uncertainties cannot explain the correla tion. In conclusion, the only hypothesis common to all approaches that can explain a common bias is the structure of the model.
The possible modifications of the model structure are without limit. Using simulations, two hypothe ses have been tested: fi rst, a possible irreversible nonspecific binding and , second, a possible endoge neous ligand . In both cases, using the correspond ing modified model, the set of simulated curves was calculated as a fu nction of B' max' the other param eters (including Kd V R) being constant and close to the mean parameter values reported in Table 3 . Then these simulated curves were fitted using the usual model ( Fig. 1 ) and the identified parameters compared with the known values used for the sim ulations. In both cases, the simulated bias intro duced in B' max and Kd V R did not give any correla tion similar to the linear correlations pointed out in this study: Kd VR was decreasing (and not increas ing) as a fu nction of B I max' and the identified Kd V R values were greater than the values used for the simulations. Consequently, the identified values of Kd V R were never very small as fo und in our results concerning the receptor-poor regions .
In conclusion, the correlation between B' max and Kd V R cannot easily be interpreted as a bias resulting from the usual hypotheses included in the ligand receptor model. Thus, if Kd is assumed to be con stant, the simplest explanation is a linear correla tion between B' max and VR resulting from the tissue inhomogeneity. Whatever the data sets , it appears that the volume of reaction increases with the re ceptor concentration.
Since the equilibrium state is rapidly reached, and assuming that the volume of distribution is in dependent of the brain region , the mean free ligand concentration [Mt (t)] can be considered t(} be inde pendent of the receptor concentration. From its def inition [ct(t) = Mt (t)IVR] ' the local free ligand con centration ct (t) in the neighborhood of the receptor sites is thus an inverse function of V R' Therefore , from the linear positive correlation between B'max and VR , this local free ligand concentration in the neighborhood of receptor sites decreases with the concentration of these receptor sites. This conclu sion is coherent since the higher the receptor con centration is, the easier the binding of free ligand and, thus, the lower the resulting local concentra tion of free ligand .
CONCLUSION
The advantages of the multiinjection modeling approach are well demonstrated in this study: It allows estimation of all the model parameters , sim ulation of the complete kinetics of the ligand , test ing of the simplified methods, and initiation of new protocols usable for patients studies. This approach can also be used for parametric imaging, as recently shown by Millet et al . (1995) , which allows visual screening of ligand transport and receptor site con centrations in the entire brain.
Concerning the model parameter estimates, the main results are the first estimation of the receptor concentration in the pons and the linear correlation between B'max and Kd VR , which is interpreted as a linear correlation between B' max and V R' This inter pretation has the advantage of being coherent : (a) The necessity of introducing a parameter V R is clearly justified by the tissue inhomogeneity ; (b) the theory claims that the dissociation constant koff is independent of V R (because of the linearity of the dissociation reaction) and that the binding probabil ity is proportional to the inverse of V R (because of the bilinearity of the association reaction) , both properties observed in the experimental results; and (c) the conclusion (the volume of reaction is in creasing with the receptor concentration) seems easily interpretable.
The equilibrium approach is the most often used quantitation method in humans. The simulation of the two-experiment Scatchard analysis using the pons as the reference region has shown that the bias on the receptor concentration estimates introduced by this approach is not negligible (from 20 to 40%), and this bias can be corrected by accounting for the presence of a low but significant receptor concen tration in the pons.
Simulations also allow proposing a new protocol, based on a Scatchard analysis of the data obtained with a partial-saturation experiment and using the pons as a reference region. The proposed protocol is entirely noninvasive, since no blood sampling is required, and thus the estimation of the benzodiaz epine receptor concentration and of the FMZ affin-ity is now possible in patients using a single I-h experiment, which is clearly acceptable for routine examination.
